Findings may have far-reaching implications for the responsiveness of cancers to epigenetic therapies Peer-Reviewed Publication BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston)—One of the major challenges in cancer research and clinical care is understanding the molecular basis for therapeutic resistance as a major cause of long term treatment failures. In cases of melanoma, the main targeted...